CNS Pharmaceuticals (CNSP) Short Interest Ratio & Short Volume $6.70 -0.29 (-4.15%) Closing price 04:00 PM EasternExtended Trading$6.88 +0.18 (+2.69%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CNS Pharmaceuticals Short Interest DataCNS Pharmaceuticals (CNSP) has a short interest of 31,200 shares. This marks a -92.18% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 31,883 shares to cover all short positions.Current Short Interest31,200 sharesPrevious Short Interest399,200 sharesChange Vs. Previous Month-92.18%Dollar Volume Sold Short$324.31 thousandShort Interest Ratio0.2 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares450,000 sharesPercentage of Shares Shorted6.93%Today's Trading Volume12,933 sharesAverage Trading Volume31,883 sharesToday's Volume Vs. Average41% Short Selling CNS Pharmaceuticals? Sign up to receive the latest short interest report for CNS Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNSP Short Interest Over TimeCNSP Days to Cover Over TimeCNSP Percentage of Float Shorted Over Time CNS Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202531,200 shares $324.31 thousand -92.2%N/A0.2 $10.39 6/30/2025399,200 shares $329.34 thousand -13.4%7.4%0.2 $0.83 6/15/2025461,100 shares $372.25 thousand +153.4%8.5%0.3 $0.81 5/31/2025182,000 shares $190.19 thousand -75.1%3.4%0.1 $1.05 5/15/2025731,700 shares $921.94 thousand +16.2%13.5%0.4 $1.26 4/30/2025629,900 shares $683.44 thousand +94.5%21.6%1.3 $1.09 4/15/2025323,800 shares $309.88 thousand -4.4%11.1%0.6 $0.96 3/31/2025338,700 shares $460.63 thousand +88.1%11.6%0.5 $1.36 3/15/2025180,100 shares $561.91 thousand -32.9%6.2%0.3 $3.12 2/28/2025268,500 shares $652.46 thousand +241.6%9.9%0.5 $2.43 Get the Latest News and Ratings for CNSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CNS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/202578,600 shares $550.20 thousand -97.8%5.2%0.1 $7.00 1/31/20253,630,000 shares $345.21 thousand -19.9%N/A0.2 $0.10 1/15/20254,530,000 shares $498.30 thousand +861.6%N/A0.2 $0.11 12/31/2024471,100 shares $56.72 thousand -64.8%N/A0 $0.12 12/15/20241,340,000 shares $137.89 thousand -35.3%N/A0.1 $0.10 11/30/20242,070,000 shares $231.84 thousand +202.9%N/A0.1 $0.11 11/15/2024683,300 shares $71.81 thousand -40.1%N/A0 $0.11 10/31/20241,140,000 shares $127.22 thousand +2.7%N/A0.1 $0.11 10/15/20241,110,000 shares $137.86 thousand +63.5%N/A0.1 $0.12 9/30/2024679,000 shares $88.61 thousand +86.2%N/A0.1 $0.13 9/15/2024364,600 shares $54.03 thousand +80.1%N/A0.1 $0.15 8/31/2024202,500 shares $31.83 thousand +87.7%N/A0 $0.16 8/15/2024107,900 shares $15.21 thousand -90.3%N/A0 $0.14 7/31/20241,110,000 shares $351.65 thousand +314.3%40.1%0.3 $0.32 7/15/2024267,900 shares $316.12 thousand +229.9%9.7%0.2 $1.18 6/30/202481,200 shares $128.30 thousand +29.7%5.8%0.1 $1.58 6/15/202462,600 shares $174.65 thousand +1,465.0%27.3%0.2 $2.79 5/31/20244,000 shares $43.24 thousand -93.6%1.8%0.2 $10.81 5/15/202462,500 shares $12.01 thousand +100.3%0.6%0.2 $0.19 4/30/202431,200 shares $6.55 thousand +35.1%0.3%0.1 $0.21 4/15/202423,100 shares $5.53 thousand -53.8%0.2%0.1 $0.24 3/31/202450,000 shares $18.10 thousand -51.8%0.5%0.1 $0.36 3/15/2024103,800 shares $36.98 thousand +91.5%1.3%0.3 $0.36 2/29/202454,200 shares $15.07 thousand -47.2%0.7%0.1 $0.28 2/15/2024102,600 shares $29.04 thousand -87.2%1.3%0.3 $0.28 1/31/2024802,400 shares $199.00 thousand +317.1%10.2%2.6 $0.25 1/15/2024192,400 shares $179.89 thousand -10.8%3.1%1.6 $0.94 12/31/2023215,700 shares $273.94 thousand +298.0%3.5%2.1 $1.27 12/15/202354,200 shares $93.77 thousand +30.6%0.9%0.5 $1.73 11/30/202341,500 shares $86.32 thousand +75.1%0.8%0.6 $2.08Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again. 11/15/202323,700 shares $45.50 thousand -50.3%0.5%0.3 $1.92 10/31/202347,700 shares $98.74 thousand -36.6%1.2%0.3 $2.07 10/15/202375,200 shares $101.52 thousand +22.7%1.8%0.5 $1.35 9/30/202361,300 shares $69.88 thousand -8.5%1.5%0.5 $1.14 9/15/202367,000 shares $100.50 thousand -45.2%1.6%0.4 $1.50 8/31/2023122,300 shares $209.13 thousand +69.6%3.0%0.6 $1.71 8/15/202372,100 shares $123.29 thousand -3.1%1.8%0.2 $1.71 7/31/202374,400 shares $168.14 thousand +11.4%1.8%0.2 $2.26 7/15/202366,800 shares $142.95 thousand -70.0%1.6%0 $2.14 6/30/2023222,600 shares $496.40 thousand +7.2%5.5%0.1 $2.23 6/15/2023207,600 shares $448.42 thousand -9.4%5.1%0.1 $2.16 5/31/2023229,100 shares $421.54 thousand +91.6%5.7%0.1 $1.84 5/15/2023119,600 shares $166.24 thousand -44.6%3.0%0 $1.39 4/30/2023215,800 shares $325.86 thousand +306.4%10.0%0.1 $1.51 4/15/202353,100 shares $124.79 thousand +410.6%3.1%0 $2.35 3/31/202310,400 shares $10.40 thousand -57.6%0.6%0 $1.00 3/15/202324,500 shares $30.38 thousand +49.4%2.3%0.6 $1.24 2/28/202316,400 shares $30.34 thousand +62.4%1.6%0.4 $1.85 2/15/202310,100 shares $17.37 thousand +206.1%1.0%0.3 $1.72 1/31/20233,300 shares $7.29 thousand +153.9%0.3%0.1 $2.21 1/15/20231,300 shares $3.12 thousand -63.9%0.1%0.1 $2.40 12/30/20223,600 shares $8.64 thousand -65.4%0.3%0.2 $2.40 12/15/202210,400 shares $26.52 thousand -2.8%0.8%0.6 $2.55 11/30/202210,700 shares $32.42 thousand -88.5%1.1%0.7 $3.03 11/15/202293,200 shares $17.72 thousand +24.4%N/A0.5 $0.19 10/31/202274,900 shares $11.98 thousand +21.2%N/A0.4 $0.16 10/15/202261,800 shares $12.66 thousand -65.7%N/A0.3 $0.20 9/30/2022180,000 shares $32.22 thousand -14.6%N/A0.7 $0.18 9/15/2022210,800 shares $51.86 thousand +15.0%N/A0.4 $0.25 8/31/2022183,300 shares $44.80 thousand -1.6%N/A0.3 $0.24 8/15/2022186,200 shares $48.21 thousand +17.7%N/A0.3 $0.26 7/31/2022158,200 shares $34.76 thousand +870.6%N/A0.3 $0.22 7/15/202216,300 shares $4.40 thousand -95.0%N/A0 $0.27 6/30/2022325,800 shares $91.22 thousand +15.4%N/A0.4 $0.28 6/15/2022282,400 shares $77.01 thousand -46.6%N/A0.3 $0.27 5/31/2022528,500 shares $160.24 thousand +80.6%N/A0.6 $0.30 5/15/2022292,600 shares $84.85 thousand -19.7%N/A0.2 $0.29 4/30/2022364,500 shares $123.20 thousand -9.5%N/A0.2 $0.34 4/15/2022402,800 shares $157.09 thousand +1,154.8%N/A0.3 $0.39 3/31/202232,100 shares $10.95 thousand -89.0%N/A0 $0.34 3/15/2022291,000 shares $93.12 thousand -46.3%1.6%0.2 $0.32 2/28/2022541,900 shares $211.34 thousand +41.6%3.1%0.4 $0.39 2/15/2022382,700 shares $133.95 thousand -69.9%2.2%0.5 $0.35 1/31/20221,270,000 shares $763.27 thousand +8.6%7.2%1.7 $0.60 1/15/20221,170,000 shares $895.05 thousand +353.7%6.6%1.6 $0.77 12/31/2021257,900 shares $181.15 thousand +8.8%1.5%0.4 $0.70 12/15/2021237,000 shares $218.18 thousand -21.5%1.4%1.1 $0.92 11/30/2021301,800 shares $338.02 thousand +16.1%1.7%1.4 $1.12 11/15/2021260,000 shares $293.80 thousand -19.7%1.5%1.3 $1.13 10/29/2021323,900 shares $446.98 thousand -10.8%1.9%2.2 $1.38Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again. 10/15/2021363,200 shares $533.90 thousand -2.6%2.1%2.7 $1.47 9/30/2021373,000 shares $555.77 thousand -16.9%2.2%2.1 $1.49 9/15/2021448,700 shares $695.49 thousand +6.9%2.6%0.9 $1.55 8/31/2021419,600 shares $713.32 thousand 0.0%2.6%0.8 $1.70 8/13/2021419,700 shares $700.90 thousand -3.9%2.6%0.8 $1.67 7/30/2021436,900 shares $751.47 thousand -28.0%2.9%0.9 $1.72 7/15/2021607,000 shares $1.09 million +57.5%4.0%1.2 $1.80 6/30/2021385,400 shares $755.38 thousand +30.4%2.6%0.8 $1.96 6/15/2021295,600 shares $588.24 thousand +1.2%2.0%1.9 $1.99 5/28/2021292,100 shares $540.39 thousand -12.7%1.9%1.3 $1.85 5/14/2021334,400 shares $571.82 thousand +11.1%2.2%1.2 $1.71 4/30/2021300,900 shares $616.85 thousand -4.2%2.0%0.5 $2.05 4/15/2021314,100 shares $669.03 thousand -17.0%2.1%0.2 $2.13 3/31/2021378,400 shares $877.89 thousand -26.9%2.5%0.2 $2.32 3/15/2021517,400 shares $1.38 million -1.4%3.4%0.2 $2.67 2/26/2021524,900 shares $1.51 million +0.8%3.5%0.2 $2.88 2/12/2021520,600 shares $1.92 million +688.8%3.6%0.2 $3.68 1/29/202166,000 shares $119.46 thousand -53.2%0.5%0 $1.81 1/15/2021140,900 shares $264.89 thousand +13.7%1.0%0.1 $1.88 12/31/2020123,900 shares $219.30 thousand +89.7%0.9%0.1 $1.77 12/15/202065,300 shares $158.68 thousand -4.3%0.9%0.1 $2.43 11/30/202068,200 shares $163.68 thousand -15.0%1.0%1.4 $2.40 11/15/202080,200 shares $170.02 thousand +6.5%1.2%1.1 $2.12 10/30/202075,300 shares $134.79 thousand -1.3%1.2%0.8 $1.79 10/15/202076,300 shares $144.97 thousand -10.7%1.2%0.8 $1.90 9/30/202085,400 shares $150.30 thousand -5.6%1.3%0.8 $1.76 9/15/202090,500 shares $177.38 thousand -25.6%1.4%0.9 $1.96 8/31/2020121,700 shares $261.66 thousand +32.4%1.9%0.9 $2.15 8/14/202091,900 shares $162.66 thousand -9.6%1.4%0.9 $1.77 CNSP Short Interest - Frequently Asked Questions What is CNS Pharmaceuticals' current short interest? Short interest is the volume of CNS Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 31,200 shares of CNSP short. Learn More on CNS Pharmaceuticals' current short interest. Is CNS Pharmaceuticals' short interest increasing or decreasing? CNS Pharmaceuticals saw a decline in short interest in July. As of July 15th, there was short interest totaling 31,200 shares, a decline of 92.2% from the previous total of 399,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CNS Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CNS Pharmaceuticals: Citius Pharmaceuticals, Inc. (10.64%), AlloVir, Inc. (2.56%), ProPhase Labs, Inc. (0.35%), NextCure, Inc. (1.36%), Lixte Biotechnology Holdings, Inc. (5.43%), Carisma Therapeutics Inc. (2.73%), Sensei Biotherapeutics, Inc. (0.87%), TherapeuticsMD, Inc. (0.16%), Trinity Biotech PLC (2.12%), Leap Therapeutics, Inc. (6.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short CNS Pharmaceuticals stock? Short selling CNSP is an investing strategy that aims to generate trading profit from CNS Pharmaceuticals as its price is falling. CNSP shares are trading down $0.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CNS Pharmaceuticals? A short squeeze for CNS Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNSP, which in turn drives the price of the stock up even further. How often is CNS Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNSP, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Citius Pharmaceuticals Short Interest Data AlloVir Short Interest Data ProPhase Labs Short Interest Data NextCure Short Interest Data Lixte Biotechnology Short Interest Data Carisma Therapeutics Short Interest Data Sensei Biotherapeutics Short Interest Data TherapeuticsMD Short Interest Data Trinity Biotech Short Interest Data Leap Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNSP) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
